Institute for International Research

Our 2007 Early to Late Stage Bioprocess Development Summit was a success! If you missed the event, you can still order a handbook. They are now available to purchase for $399 (plus shipping).

Keynote Presentations Extended Product Development Case Study: Lumiliximab John Pieracci, Ph.D., Senior Engineer, Purification Development; Michael Molony, Senior Manager, Biopharmaceutical Development Division; and Nuzhat Pathan, Ph.D., Senior Scientist, Molecular Discovery; Biogen Idec Pay Me Now or Pay Me Later: Managing the Transition from Early to Late Phase Product Development William F. Heath, Jr., Ph.D., Executive Director, Bioproduct Research and Development, Lilly Research Laboratories Scientific Strategies Learn how to increase the pace and quality of Process Development through implementing Quality by Design, single-use components and platform-oriented facility design Accelerate Analytical Development by improving the discovery-development handoff and using an accelerated development strategy Interactive Program Features Pre-Conference Workshop: Increasing the Product Value of Biotherapeutics through Improved CMC Development Facilitated Small Group Problem-Solving Discussio

By attending IBC's 4th annual meeting, you will learn how to treat your development plan as a continuum that ranges from the discovery handoff all the way through to phase III clinical studies. By adopting this approach, your organization will preserve scarce resources, integrate information flows among different unit operations and implement time-saving platforming of key functions. The Early to Late Stage Bioprocess Development Summit gives you the opportunity to benchmark your process and analytical development programs against those of other industry companies, and to explore best practices that can be applied right away to your own operations.

Program highlights for 2007 include:

• Amgen, Centocor, Human Genome Sciences, Medarex and XOMA show you critical steps to be taken early development to improve product value and manufacturability
• Biogen Idec presents a unique three-part extended case study showing the full spectrum of early to late stage development activity for a product now in phase III trials
• Eli Lilly and Company demonstrates how information and material generation are balanced to improve the robustness of late-stage production processes
• Wyeth Biopharma teaches you how its analytical support and characterization work has been accelerated to keep pace with aggressive product-development timelines

Plus, select from six different small group problem-solving discussions to receive feedback from your peers on problems specific to your company size or stage of development:

• Program and Project Management for Scientists: How to Effectively Work in Cross-Functional Program Teams
• Improving the Product Handoff from the Discovery Function to Development
• Balancing Product Yield and Quality in Clone Selection and Early Cell Culture Development
• Optimizing Inter-function, Inter-site and Company-CMO Transfers in Biologics Development
• Early Formulation and Dosage Form Development (High Concentration Proteins, Prefilled Syringes, Novel Delivery Methods)
• How to Effectively Use and Validate Next-Generation Analytical Tools for Product Characterization

Register today to take advantage of early discounts, and use the generous team discount to allow more members of your lab group to attend. See the registration page for details.